Skip to content

Randomised trial, 2025

Does open-label placebo (knowing it is placebo) help with PMS symptoms?

Yes, when women received placebo pills with a clear explanation of how placebos work, it reduced PMS symptoms compared to usual care and placebo without explanation. This shows the importance of expectation and explanation.

Strong study design 150 women aged 18-45 years with PMS or PMDD in Switzerland

What they did

A three-arm randomized trial in Switzerland with 150 women aged 18-45 years with PMS or PMDD. One group received usual treatment. One received open-label placebo without explanation. One received open-label placebo with a treatment explanation. All took pills for 6 weeks. Outcomes were measured over three menstrual cycles.

What they found

At menstrual cycle 3, placebo with explanation reduced symptom intensity more than usual care (by 9.97 points, p<0.001) and more than placebo without explanation (by 6.10 points, p=0.036). It reduced symptom interference more than usual care (by 1.23 points, p=0.022) and placebo without explanation (by 1.10 points, p=0.044). 145 of 150 women (96.7%) completed the study.

What it means for you

Placebo pills work better when combined with a clear explanation of how placebos help, even when women know they are placebos. This shows explanation and expectation matter for symptom improvement. The study was rigorous and well-completed, but it is unclear how long benefits last.

150

women randomized

145 (96.7%)

women who completed the study

6 weeks

duration of treatment

About the study

Original title
Efficacy of open-label placebos for premenstrual syndrome: a randomised controlled trial
Authors
Frey Nascimento A, Gaab J, Degen B et al.
Journal
BMJ evidence-based medicine
Year
2025
Study design
Randomised trial
Participants
50
What was tested
Open-label placebo pills with or without treatment explanation for 6 weeks versus usual care
Open access
Yes

Topics